Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-075193

Director acquired 46,188 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Tullman Stephen A. Director 2015-10-13 Conversion +46,188 394,014 I
Derivatives
Tullman Stephen A. Director 2015-10-13 Conversion · Series A Preferred Stock −110,000 0 I
Tullman Stephen A. Director 2015-10-13 Conversion · Series B Preferred Stock −31,913 0 I
Tullman Stephen A. Director 2015-10-13 Conversion · Series C Preferred Stock −17,437 0 I
Loading xslF345X03/doc4.xml…